| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2015-11-10 | Epirus Biopharmaceuticals (USA - MA) | nomination |
Nomination | |||
| 2015-11-10 | Nicox (France) Fera Pharmaceuticals (USA - NY) | naproxcinod | osteoarthritis | licensing |
Rheumatic diseases - Inflammatory diseases | Licensing agreement |
| 2015-11-10 | Asceneuron (Switzerland) | chairman of the board of directors | nomination | Neurodegenerative diseases | Nomination | |
| 2015-11-09 | Strongbridge Biopharma (Ireland) | nomination |
Rare diseases | Nomination | ||
| 2015-11-09 | Bone Therapeutics (Belgium) | nomination |
Bone diseases - Regenerative medicine | Nomination | ||
| 2015-11-09 | Warp Drive Bio (USA - MA) | nomination |
Cancer - Oncology | Nomination | ||
| 2015-11-09 | Janssen Pharmaceuticals, a J&J company (USA - NJ) Hanmi Pharmaceutical (South Korea) | oxyntomodulin-based therapies including HM12525A | diabetes | licensing |
Metabolic diseases | Licensing agreement |
| 2015-11-09 | Valneva (France- Austria) VaxServe (USA - PA) , a Sanofi Pasteur company (France) | Ixiaro® | Japanese encephalitis | distribution |
Infectious diseases | Distribution agreement |
| 2015-11-09 | Mereo Biopharma (UK) | nomination |
Nomination | |||
| 2015-11-07 | Oryzon Genomics (Spain) | nomination |
Cancer - Oncology - Neurodegenerative diseases | Nomination | ||
| 2015-11-06 | Boehringer Ingelheim (Germany) | nomination |
Nomination | |||
| 2015-11-06 | Sanofi (France) Lexicon Pharmaceuticals (USA - TX) | sotagliflozin (LX4211) | type 1 diabetes, type 2 diabetes | licensing - collaboration | Metabolic diseases | Licensing agreement |
| 2015-11-05 | Hanmi Pharmaceutical (South Korea) Sanofi (France) | long-acting diabetes treatments including efpeglenatide, a weekly insulin and a fixed-dosed weekly GLP-1-RA/insulin drug combination | diabetes | licensing |
Metabolic diseases | Licensing agreement |
| 2015-11-05 | RedXPharma (UK) | nomination |
Nomination | |||
| 2015-11-05 | Xoma (USA - CA) Agenus (USA - MA) | antibody pilot plant manufacturing facilities | plant acquisition |
Technology - Services | Plant acquisition | |
| 2015-11-05 | Agenus (USA - MA) Iontas (UK) | phage display library | licensing |
Technology - Services | Licensing agreement | |
| 2015-11-05 | Agenus (USA - MA) Selexis (Switzerland) | cell line development technology | licensing |
Technology - Services | Licensing agreement | |
| 2015-11-05 | Xoma (USA - CA) Nanotherapeutics (USA - FL) | biodefense program | pipeline acquisition |
Infectious diseases | Pipeline acquisition | |
| 2015-11-05 | Epirus Biopharmaceuticals (USA - MA) Biosimilars Forum (USA) | collaboration |
Collaboration agreement | |||
| 2015-11-04 | Galapagos (Belgium) | nomination |
Nomination |
